Arvinas (ARVN) EBT (2017 - 2026)
Arvinas' (ARVN) quarterly EBT came in at -$57.5 million in Q1 2026, down 169.19% year-on-year from $83.1 million in Q1 2025, and up 14.43% quarter-over-quarter from -$67.2 million in Q4 2025.
Arvinas (ARVN) EBT (2017 - 2026) Analysis & Trends
Arvinas' EBT history runs 10 years deep, the most recent figure standing at -$57.5 million for Q1 2026.
- On a quarterly basis, EBT fell 169.19% year-over-year to -$57.5 million in Q1 2026; TTM through Mar 2026 was -$221.0 million, a 380.43% decrease from a year earlier, with the FY2025 full-year figure at -$80.5 million, up 59.4% from the prior year.
- EBT improved to -$57.5 million in Q1 2026 per ARVN's latest filing, from -$67.2 million in the prior quarter.
- Across five years, EBT topped out at $83.1 million in Q1 2025 and bottomed at -$153.2 million in Q4 2023.
- The 5-year median for EBT is -$61.5 million (2025), against an average of -$56.0 million.
- Across the five-year window, EBT jumped 219.91% in 2025 and plunged 169.19% in 2026, its largest moves.
- Year by year, EBT stood at -$69.3 million in 2022, then slumped by 121.07% to -$153.2 million in 2023, then soared by 70.3% to -$45.5 million in 2024, then sank by 47.69% to -$67.2 million in 2025, then grew by 14.43% to -$57.5 million in 2026.
- Per Business Quant, the three latest ARVN EBT figures stand at -$57.5 million (Q1 2026), -$67.2 million (Q4 2025), and -$34.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.31 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 259.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 438.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Arvinas | 512.64 Mn | -102.26 Mn | - | -57.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -57.50 Mn |
| Dec 31, 2025 | -67.20 Mn |
| Sep 30, 2025 | -34.80 Mn |
| Jun 30, 2025 | -61.50 Mn |
| Mar 31, 2025 | 83.10 Mn |
| Dec 31, 2024 | -45.50 Mn |
| Sep 30, 2024 | -48.60 Mn |
| Jun 30, 2024 | -35.00 Mn |
| Mar 31, 2024 | -69.30 Mn |
| Dec 31, 2023 | -153.20 Mn |
| Sep 30, 2023 | -63.90 Mn |
| Jun 30, 2023 | -65.60 Mn |
| Mar 31, 2023 | -81.20 Mn |
| Dec 31, 2022 | -69.30 Mn |
| Sep 30, 2022 | -61.10 Mn |
| Jun 30, 2022 | -64.10 Mn |
| Mar 31, 2022 | -56.60 Mn |
| Dec 31, 2021 | -46.10 Mn |
| Sep 30, 2021 | -46.80 Mn |
| Jun 30, 2021 | -50.30 Mn |